T1	Drug 29 48	systemic medication
T2	Drug 14 21;38 48	topical medication
*	OR T1 T2 T3
T3	Device 52 70	mechanical devices
T4	Drug 136 160	topical immunomodulators
T5	Device 162 175	punctal plugs
T6	Drug 177 192	corticosteroids
T7	Drug 194 223	preservative artificial tears
T8	Device 225 239	contact lenses
*	OR T4 T5 T8 T7 T6
T9	Scope 136 239	topical immunomodulators, punctal plugs, corticosteroids, preservative artificial tears, contact lenses
T10	Scope 14 70	topical and/or systemic medication or mechanical devices
R1	Subsumes Arg1:T10 Arg2:T9	
T11	Person 253 260	females
T12	Observation 267 285	active sexual life
T13	Negation 294 297	not
T14	Procedure 304 324	contraceptive method
R2	Has_negation Arg1:T14 Arg2:T13	
T15	Person 327 333	Female
T16	Condition 351 359	pregnant
T17	Condition 363 372	lactating
*	OR T16 T17
T18	Person 374 380	Female
T19	Value 397 405	positive
T20	Measurement 406 426	urine pregnancy test
R3	Has_value Arg1:T20 Arg2:T19	
T21	Condition 428 452	Positive drug addictions
T22	Procedure 455 475	verbal interrogatory
R4	AND Arg1:T21 Arg2:T22	
T23	Competing_trial 478 566	Subjects who have participated on any other research clinical trials on the last 40 days
T24	Condition 586 603	mentally disabled
T25	Condition 577 582;595 603	legal disabled
*	OR T24 T25
T26	Informed_consent 568 663	Subjects legal or mentally disabled to give an informed consent for participating on this study
T27	Non-query-able 665 748	Subjects who can't comply with the appointments or with every protocol requirement.
T28	Condition 750 788	Serious tear film dysfunction syndrome
T29	Measurement 789 793	TBUT
T30	Line 750 788	Serious tear film dysfunction syndrome
T31	Value 794 799	< 5 s
R5	Has_value Arg1:T29 Arg2:T31	
T32	Measurement 800 808	Schirmer
T33	Value 810 816	< 4 mm
R6	Has_value Arg1:T32 Arg2:T33	
T34	Measurement 817 821	OSDI
T35	Value 822 832	> 30 pints
T36	Measurement 833 849	Corneal staining
T37	Value 850 861	> grade III
T38	Qualifier 869 881	Oxford scale
R7	Has_qualifier Arg1:T36 Arg2:T38	
R8	Has_value Arg1:T36 Arg2:T37	
R9	Has_value Arg1:T34 Arg2:T35	
T39	Line 789 799	TBUT < 5 s
T40	Line 800 816	Schirmer: < 4 mm
T41	Line 817 832	OSDI > 30 pints
T42	Line 833 881	Corneal staining > grade III on the Oxford scale
T43	Qualifier 883 897	Non perforated
T44	Condition 898 911	corneal ulcer
R10	Has_qualifier Arg1:T44 Arg2:T43	
T45	Condition 924 937	corneal ulcer
T46	Qualifier 913 923	Perforated
R11	Has_qualifier Arg1:T45 Arg2:T46	
T47	Condition 950 963	corneal ulcer
T48	Qualifier 939 949	Autoimmune
R12	Has_qualifier Arg1:T47 Arg2:T48	
T49	Condition 965 997	Ocular surface scarring diseases
T50	Condition 1037 1044;999 1013	lesions Ocular surface
T51	Condition 1017 1044;999 1005	annexes metaplastic lesions Ocular
*	OR T50 T51
T52	Condition 1046 1082	Fibro vascular proliferation lesions
T53	Qualifier 1110 1125	corneal surface
T54	Qualifier 1090 1102	conjunctival
*	OR T53 T54
T55	Qualifier 1133 1142	pterygium
T56	Scope 1090 1125	conjunctival and/or corneal surface
R13	Subsumes Arg1:T56 Arg2:T55	
R14	Has_scope Arg1:T52 Arg2:T56	
T57	Temporal 1145 1156	Concomitant
T58	Condition 1157 1186	chronic inflammatory diseases
T59	Qualifier 1194 1210	ocular structure
R15	Has_qualifier Arg1:T58 Arg2:T59	
R16	Has_temporal Arg1:T58 Arg2:T57	
T60	Condition 1232 1252	inflammatory disease
T61	Qualifier 1212 1217	Acute
T62	Qualifier 1221 1231	infectious
*	OR T62 T61
T63	Scope 1212 1231	Acute or infectious
R17	Has_scope Arg1:T60 Arg2:T63	
T64	Condition 1254 1269	Corneal disease
T65	Procedure 1294 1303	treatment
T66	Mood 1270 1291	potentially requiring
R18	Has_mood Arg1:T65 Arg2:T66	
T67	Temporal 1304 1333	during the following 3 months
R19	AND Arg1:T64 Arg2:T65	
R20	Has_temporal Arg1:T65 Arg2:T67	
T68	Non-representable 1335 1399	Use of topical or systemic drug products classified as forbidden
T69	Procedure 1401 1427	Ocular surgical procedures
T70	Temporal 1428 1467	3 months before the protocol inclusion
T71	Reference_point 1448 1466	protocol inclusion
T72	Temporal 1428 1466	3 months before the protocol inclusion
R21	Has_index Arg1:T72 Arg2:T71	
R22	Has_temporal Arg1:T69 Arg2:T72	
T73	Procedure 1468 1478	Treatments
T74	Procedure 1482 1492	procedures
T75	Procedure 1510 1541	tear film dysfunction treatment
T76	Device 1546 1568	punctal silicone plugs
*	OR T74 T73
T77	Scope 1468 1492	Treatments or procedures
R23	Has_scope Arg1:T75 Arg2:T77	
R24	AND Arg1:T75 Arg2:T76	
T78	Condition 1571 1597	Posterior segment diseases
T79	Procedure 1610 1619	treatment
T80	Condition 1623 1655	threatening the visual prognosis
*	OR T79 T80
T81	Mood 1598 1607	requiring
R25	Has_mood Arg1:T79 Arg2:T81	
T82	Scope 1598 1655	requiring a treatment or threatening the visual prognosis
R26	Has_scope Arg1:T78 Arg2:T82	
T83	Device 1783 1802	hard contact lenses
T84	Procedure 1748 1772	penetrating keratoplasty
T85	Temporal 1706 1735	during the following 3 months
T86	Procedure 1696 1705	treatment
T87	Mood 1686 1695	requiring
R27	Has_mood Arg1:T86 Arg2:T87	
R28	Has_temporal Arg1:T86 Arg2:T85	
T88	Condition 1657 1673	Retinal diseases
R29	AND Arg1:T88 Arg2:T86	
T89	Observation 1737 1744	History
R30	Has_temporal Arg1:T84 Arg2:T89	
T90	Device 1775 1779;1788 1802	Soft contact lenses
*	OR T83 T90
T91	Temporal 1807 1847	during the last month from inclusion day
T92	Reference_point 1834 1847	inclusion day
R31	Has_index Arg1:T91 Arg2:T92	
T93	Scope 1775 1802	Soft or hard contact lenses
R32	Has_temporal Arg1:T93 Arg2:T91	
